Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane Followed by FEC in Locally Advanced Breast Cancer
NCT00110695Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Apr 2005
- Primary completion
- Dec 2006
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel in breast cancer, sponsored by NSABP Foundation. Primary endpoint: Pathologic Complete Response Rate in the Breast. Started Apr 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00110695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110695.